The use of nonoxynol-9 for protection against cervical gonorrhea
Although condoms are the best defense against sexually transmitted disease, little is known about the effectiveness of female-controlled methods containing nonoxynol-9 as backup protection when condoms are not being used. To assess the extent to which nonoxynol-9 protects women against gonorrhea, a...
Gespeichert in:
Veröffentlicht in: | American journal of public health (1971) 1994-06, Vol.84 (6), p.910-914 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 914 |
---|---|
container_issue | 6 |
container_start_page | 910 |
container_title | American journal of public health (1971) |
container_volume | 84 |
creator | Weir, S S Feldblum, P J Zekeng, L Roddy, R E |
description | Although condoms are the best defense against sexually transmitted disease, little is known about the effectiveness of female-controlled methods containing nonoxynol-9 as backup protection when condoms are not being used.
To assess the extent to which nonoxynol-9 protects women against gonorrhea, a cohort of 303 female sex workers (prostitutes) in Yaounde, Cameroon, were asked to use condoms and suppositories containing nonoxynol-9 at every sexual encounter and to record daily sexual activity and use of condoms and suppositories on coital logs that were reviewed monthly. Evidence of gonorrheal infection was based on a positive gonorrhea culture. Stratified analysis and proportional hazards regression were used to estimate rate ratios.
Forty-one women enrolled in the study were excluded from the current analysis. The estimated incidence of gonorrhea was 6.2 infections per 100 person-months of observation. Incidence rate ratios estimated from proportional hazards regression models controlling for condom use showed that using nonoxynol-9 during acts not protected by condoms reduced the risk of infection.
Although the protective effect of condoms against sexually transmitted disease is greater than that afforded by nonoxynol-9, using nonoxynol-9 when condoms are not used is a far better strategy in gonorrhea prevention than using no method at all. |
doi_str_mv | 10.2105/AJPH.84.6.910 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1614944</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76529607</sourcerecordid><originalsourceid>FETCH-LOGICAL-c559t-f0956bc612f82dc954ea6dc41118d0e7ba5e8d3a33ac3d58e8a6668d405f8a483</originalsourceid><addsrcrecordid>eNqNksFrFDEUxoModa0ePQqDirdZ8zJJJrkUS1GrFPRQz-FtJrOTZTZZk5lq_3uzdFmqIHpKyPfjC-97HyHPgS4ZUPH2_PPXy6XiS7nUQB-QBQgONaVcPSQLSjUt90Y-Jk9y3lAKoAWckBPFyqMSC_LuenDVnF0V-yrEEH_ehjjWuupjqnYpTs5OPoYK1-hDnirr0o23OFbrwqY0OHxKHvU4ZvfscJ6Sbx_eX19c1ldfPn66OL-qrRB6qnuqhVxZCaxXrLNacIeysxwAVEddu0LhVNdg06BtOqGcQiml6jgVvUKumlNydue7m1db11kXpoSj2SW_xXRrInrzuxL8YNbxxoAErjkvBm8OBil-n12ezNZn68YRg4tzNq0UTEva_hME1Wqm-H-AshWiTFHAl3-AmzinUOIyDAQAp0oU6NXfIGBaNUxJvbeq7yibYs7J9ccEgJp9H8y-D0ZxI03pQ-Ff3I_tSB8KUPTXBx1z2WufMFifjxgHqqi-N-rg18MPn5zJWxzHYgoGN7vh-N8vAeDJNw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>215114085</pqid></control><display><type>article</type><title>The use of nonoxynol-9 for protection against cervical gonorrhea</title><source>MEDLINE</source><source>PAIS Index</source><source>Business Source Complete</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Periodicals Index Online</source><creator>Weir, S S ; Feldblum, P J ; Zekeng, L ; Roddy, R E</creator><creatorcontrib>Weir, S S ; Feldblum, P J ; Zekeng, L ; Roddy, R E</creatorcontrib><description>Although condoms are the best defense against sexually transmitted disease, little is known about the effectiveness of female-controlled methods containing nonoxynol-9 as backup protection when condoms are not being used.
To assess the extent to which nonoxynol-9 protects women against gonorrhea, a cohort of 303 female sex workers (prostitutes) in Yaounde, Cameroon, were asked to use condoms and suppositories containing nonoxynol-9 at every sexual encounter and to record daily sexual activity and use of condoms and suppositories on coital logs that were reviewed monthly. Evidence of gonorrheal infection was based on a positive gonorrhea culture. Stratified analysis and proportional hazards regression were used to estimate rate ratios.
Forty-one women enrolled in the study were excluded from the current analysis. The estimated incidence of gonorrhea was 6.2 infections per 100 person-months of observation. Incidence rate ratios estimated from proportional hazards regression models controlling for condom use showed that using nonoxynol-9 during acts not protected by condoms reduced the risk of infection.
Although the protective effect of condoms against sexually transmitted disease is greater than that afforded by nonoxynol-9, using nonoxynol-9 when condoms are not used is a far better strategy in gonorrhea prevention than using no method at all.</description><identifier>ISSN: 0090-0036</identifier><identifier>EISSN: 1541-0048</identifier><identifier>DOI: 10.2105/AJPH.84.6.910</identifier><identifier>PMID: 8203685</identifier><identifier>CODEN: AJPEAG</identifier><language>eng</language><publisher>Washington, DC: Am Public Health Assoc</publisher><subject>Administration, Intravaginal ; Adult ; Bacterial diseases ; Biological and medical sciences ; Cohort Studies ; Condoms ; Drug therapy ; Female ; Gonorrhea ; Gonorrhea - prevention & control ; Human bacterial diseases ; Humans ; Infectious diseases ; Medical research ; Medical sciences ; Middle Aged ; Miscellaneous ; Nonoxynol - administration & dosage ; Nonoxynol - therapeutic use ; Prostitution ; Public health ; Sex industry ; Sex Work ; Sexually transmitted diseases ; STD ; Suppositories ; Tropical medicine ; Uterine Cervical Diseases - prevention & control</subject><ispartof>American journal of public health (1971), 1994-06, Vol.84 (6), p.910-914</ispartof><rights>1994 INIST-CNRS</rights><rights>Copyright American Public Health Association Jun 1994</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c559t-f0956bc612f82dc954ea6dc41118d0e7ba5e8d3a33ac3d58e8a6668d405f8a483</citedby><cites>FETCH-LOGICAL-c559t-f0956bc612f82dc954ea6dc41118d0e7ba5e8d3a33ac3d58e8a6668d405f8a483</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1614944/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1614944/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27843,27846,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4108097$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8203685$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Weir, S S</creatorcontrib><creatorcontrib>Feldblum, P J</creatorcontrib><creatorcontrib>Zekeng, L</creatorcontrib><creatorcontrib>Roddy, R E</creatorcontrib><title>The use of nonoxynol-9 for protection against cervical gonorrhea</title><title>American journal of public health (1971)</title><addtitle>Am J Public Health</addtitle><description>Although condoms are the best defense against sexually transmitted disease, little is known about the effectiveness of female-controlled methods containing nonoxynol-9 as backup protection when condoms are not being used.
To assess the extent to which nonoxynol-9 protects women against gonorrhea, a cohort of 303 female sex workers (prostitutes) in Yaounde, Cameroon, were asked to use condoms and suppositories containing nonoxynol-9 at every sexual encounter and to record daily sexual activity and use of condoms and suppositories on coital logs that were reviewed monthly. Evidence of gonorrheal infection was based on a positive gonorrhea culture. Stratified analysis and proportional hazards regression were used to estimate rate ratios.
Forty-one women enrolled in the study were excluded from the current analysis. The estimated incidence of gonorrhea was 6.2 infections per 100 person-months of observation. Incidence rate ratios estimated from proportional hazards regression models controlling for condom use showed that using nonoxynol-9 during acts not protected by condoms reduced the risk of infection.
Although the protective effect of condoms against sexually transmitted disease is greater than that afforded by nonoxynol-9, using nonoxynol-9 when condoms are not used is a far better strategy in gonorrhea prevention than using no method at all.</description><subject>Administration, Intravaginal</subject><subject>Adult</subject><subject>Bacterial diseases</subject><subject>Biological and medical sciences</subject><subject>Cohort Studies</subject><subject>Condoms</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Gonorrhea</subject><subject>Gonorrhea - prevention & control</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>Nonoxynol - administration & dosage</subject><subject>Nonoxynol - therapeutic use</subject><subject>Prostitution</subject><subject>Public health</subject><subject>Sex industry</subject><subject>Sex Work</subject><subject>Sexually transmitted diseases</subject><subject>STD</subject><subject>Suppositories</subject><subject>Tropical medicine</subject><subject>Uterine Cervical Diseases - prevention & control</subject><issn>0090-0036</issn><issn>1541-0048</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>K30</sourceid><sourceid>7TQ</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNksFrFDEUxoModa0ePQqDirdZ8zJJJrkUS1GrFPRQz-FtJrOTZTZZk5lq_3uzdFmqIHpKyPfjC-97HyHPgS4ZUPH2_PPXy6XiS7nUQB-QBQgONaVcPSQLSjUt90Y-Jk9y3lAKoAWckBPFyqMSC_LuenDVnF0V-yrEEH_ehjjWuupjqnYpTs5OPoYK1-hDnirr0o23OFbrwqY0OHxKHvU4ZvfscJ6Sbx_eX19c1ldfPn66OL-qrRB6qnuqhVxZCaxXrLNacIeysxwAVEddu0LhVNdg06BtOqGcQiml6jgVvUKumlNydue7m1db11kXpoSj2SW_xXRrInrzuxL8YNbxxoAErjkvBm8OBil-n12ezNZn68YRg4tzNq0UTEva_hME1Wqm-H-AshWiTFHAl3-AmzinUOIyDAQAp0oU6NXfIGBaNUxJvbeq7yibYs7J9ccEgJp9H8y-D0ZxI03pQ-Ff3I_tSB8KUPTXBx1z2WufMFifjxgHqqi-N-rg18MPn5zJWxzHYgoGN7vh-N8vAeDJNw</recordid><startdate>19940601</startdate><enddate>19940601</enddate><creator>Weir, S S</creator><creator>Feldblum, P J</creator><creator>Zekeng, L</creator><creator>Roddy, R E</creator><general>Am Public Health Assoc</general><general>American Public Health Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>HDMVH</scope><scope>IBDFT</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7TQ</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>88J</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DHY</scope><scope>DON</scope><scope>DPSOV</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K60</scope><scope>K6~</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KC-</scope><scope>L.-</scope><scope>LK8</scope><scope>M0C</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2L</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M2R</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PATMY</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>S0X</scope><scope>7QL</scope><scope>C1K</scope><scope>7TS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19940601</creationdate><title>The use of nonoxynol-9 for protection against cervical gonorrhea</title><author>Weir, S S ; Feldblum, P J ; Zekeng, L ; Roddy, R E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c559t-f0956bc612f82dc954ea6dc41118d0e7ba5e8d3a33ac3d58e8a6668d405f8a483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Administration, Intravaginal</topic><topic>Adult</topic><topic>Bacterial diseases</topic><topic>Biological and medical sciences</topic><topic>Cohort Studies</topic><topic>Condoms</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Gonorrhea</topic><topic>Gonorrhea - prevention & control</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>Nonoxynol - administration & dosage</topic><topic>Nonoxynol - therapeutic use</topic><topic>Prostitution</topic><topic>Public health</topic><topic>Sex industry</topic><topic>Sex Work</topic><topic>Sexually transmitted diseases</topic><topic>STD</topic><topic>Suppositories</topic><topic>Tropical medicine</topic><topic>Uterine Cervical Diseases - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weir, S S</creatorcontrib><creatorcontrib>Feldblum, P J</creatorcontrib><creatorcontrib>Zekeng, L</creatorcontrib><creatorcontrib>Roddy, R E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Periodicals Index Online Segment 15</collection><collection>Periodicals Index Online Segment 27</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access & Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access & Build (Plan A) - APAC</collection><collection>Primary Sources Access & Build (Plan A) - Canada</collection><collection>Primary Sources Access & Build (Plan A) - West</collection><collection>Primary Sources Access & Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - Midwest</collection><collection>Primary Sources Access & Build (Plan A) - North Central</collection><collection>Primary Sources Access & Build (Plan A) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>PAIS Index</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>Politics Collection</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Politics Collection</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ProQuest Biological Science Collection</collection><collection>ABI/INFORM Global</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Political Science Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Social Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Environmental Science Database</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Physical Education Index</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of public health (1971)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weir, S S</au><au>Feldblum, P J</au><au>Zekeng, L</au><au>Roddy, R E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The use of nonoxynol-9 for protection against cervical gonorrhea</atitle><jtitle>American journal of public health (1971)</jtitle><addtitle>Am J Public Health</addtitle><date>1994-06-01</date><risdate>1994</risdate><volume>84</volume><issue>6</issue><spage>910</spage><epage>914</epage><pages>910-914</pages><issn>0090-0036</issn><eissn>1541-0048</eissn><coden>AJPEAG</coden><abstract>Although condoms are the best defense against sexually transmitted disease, little is known about the effectiveness of female-controlled methods containing nonoxynol-9 as backup protection when condoms are not being used.
To assess the extent to which nonoxynol-9 protects women against gonorrhea, a cohort of 303 female sex workers (prostitutes) in Yaounde, Cameroon, were asked to use condoms and suppositories containing nonoxynol-9 at every sexual encounter and to record daily sexual activity and use of condoms and suppositories on coital logs that were reviewed monthly. Evidence of gonorrheal infection was based on a positive gonorrhea culture. Stratified analysis and proportional hazards regression were used to estimate rate ratios.
Forty-one women enrolled in the study were excluded from the current analysis. The estimated incidence of gonorrhea was 6.2 infections per 100 person-months of observation. Incidence rate ratios estimated from proportional hazards regression models controlling for condom use showed that using nonoxynol-9 during acts not protected by condoms reduced the risk of infection.
Although the protective effect of condoms against sexually transmitted disease is greater than that afforded by nonoxynol-9, using nonoxynol-9 when condoms are not used is a far better strategy in gonorrhea prevention than using no method at all.</abstract><cop>Washington, DC</cop><pub>Am Public Health Assoc</pub><pmid>8203685</pmid><doi>10.2105/AJPH.84.6.910</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0090-0036 |
ispartof | American journal of public health (1971), 1994-06, Vol.84 (6), p.910-914 |
issn | 0090-0036 1541-0048 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1614944 |
source | MEDLINE; PAIS Index; Business Source Complete; PubMed Central; Alma/SFX Local Collection; Periodicals Index Online |
subjects | Administration, Intravaginal Adult Bacterial diseases Biological and medical sciences Cohort Studies Condoms Drug therapy Female Gonorrhea Gonorrhea - prevention & control Human bacterial diseases Humans Infectious diseases Medical research Medical sciences Middle Aged Miscellaneous Nonoxynol - administration & dosage Nonoxynol - therapeutic use Prostitution Public health Sex industry Sex Work Sexually transmitted diseases STD Suppositories Tropical medicine Uterine Cervical Diseases - prevention & control |
title | The use of nonoxynol-9 for protection against cervical gonorrhea |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T11%3A04%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20use%20of%20nonoxynol-9%20for%20protection%20against%20cervical%20gonorrhea&rft.jtitle=American%20journal%20of%20public%20health%20(1971)&rft.au=Weir,%20S%20S&rft.date=1994-06-01&rft.volume=84&rft.issue=6&rft.spage=910&rft.epage=914&rft.pages=910-914&rft.issn=0090-0036&rft.eissn=1541-0048&rft.coden=AJPEAG&rft_id=info:doi/10.2105/AJPH.84.6.910&rft_dat=%3Cproquest_pubme%3E76529607%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=215114085&rft_id=info:pmid/8203685&rfr_iscdi=true |